A
Aclaris Therapeutics, Inc.ACRS
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D.
US StocksHealthcareSmall CapBiotechnology
ACRS Price Trend
Aclaris Therapeutics, Inc. · Full TradingView Chart
NASDAQ:ACRS